Human CD27 is a lymphocyte-specific member of the TNF receptor superfamily. CD27 is expressed on a subset of human thymocytes and on the majority of mature T cells. CD27 expression is up-regulated after TCR stimulation. Within the CD4+ compartment, it is preferentially expressed on CD45RA+ cells. In contrast, it is preferentially expressed on CD45RO+ cells in the CD8+ compartment. CD27 also appears to be a potential marker for memory B cells. It exists as both a disulfide‑linked dimer on the cell surface and as a soluble protein found in serum. Human CD27 is a 260 amino acid (aa) protein with a 20 aa signal, a 173 aa extracellular domain, a 20 aa transmembrane domain, and a 47 aa cytoplasmic domain. The ligand for CD27 is CD70. CD70 is expressed on thymic stromal cells and a small subset of activated T cells. Additionally a subset of activated B cells express CD70. The CD27/CD70 interaction appears to be a weak costimulatory pathway involved in T cell and B cell immune response. CD27/CD70 interactions may be more involved in controlling the expansion phase of an immune response. This would be in contrast to B7/CD28 interactions, which are important for the activation phase of immune responses.
Human CD27/TNFRSF7 Antibody (57703)
R&D Systems | Catalog # MAB382
Scientific images may be resized, cropped, or adjusted for brightness or contrast for presentation purposes. These updates are limited to presentation and do not affect the underlying scientific interpretation of the data. Where available, additional source data may be provided upon request.
Key Product Details
Species Reactivity
Validated:
Cited:
Applications
Validated:
Cited:
Label
Antibody Source
Product Specifications
Immunogen
Thr21-Ile192
Accession # P26842
Specificity
Clonality
Host
Isotype
Endotoxin Level
Scientific Data Images for Human CD27/TNFRSF7 Antibody (57703)
CD27/TNFRSF7 Inhibition of CD27 Ligand/TNFSF7-dependent Cell Proliferation and Neutralization by Human CD27/TNFRSF7 Antibody.
In the presence of sub-optimal amounts of Mouse CD3e Monoclonal Anti-body (Catalog # MAB484) and Recombinant Mouse CD27 Ligand (10 µg/mL, Catalog # 783-CL), Recombinant Human CD27 Fc Chimera (Catalog # 382-CD) inhibits proliferation in mouse splenic T cells in a dose-dependent manner (orange line). Under these conditions, inhibition of proliferation elicited by Recombinant Human CD27 Fc Chimera (3 µg/mL) is neutralized (green line) by increasing concentrations of Mouse Anti-Human CD27 Monoclonal Antibody (Catalog # MAB382). The ND50 is typically 0.2-0.4 µg/mL.Detection of CD27/TNFRSF7 by Flow Cytometry
CD70-CAR NK cell development and validation. A Schematic representation of CD70-CAR NK cell generation and structural composition of the CD70-CAR construct. B CD70-CAR expression was detected by measuring CD27 expression on the cell surface using flow cytometry. Representative histograms of CD27 expression on NK-92 cells 4 h, 24 h, 48 h and 72 h after electroporation without (MOCK; white) or with CAR-encoding mRNA (CD70-CAR; blue). C Quantification of the amount CD27+ cells and the intensity of CD27 expression, depicted as mean fluorescence intensity minus isotype control ( delta MFI), 24 h post-electroporation (n = 6). D Percentage of viable Raji cells after a 4 h co-culture with CD70-CAR NK cells or MOCK control cells in the presence of 10 μg/mL anti-CD27 blocking antibody (CD27-block; red) or corresponding isotype control (Isotype; black; n = 4). E Representative flow cytometry histograms of CD70 expression on tumor cell lines (Raji, PANC-1, and LIM2099). F-G Quantification of percentage CD70+ cells and intensity of CD70 expression ( delta MFI) for Raji, PANC-1, and LIM2099 tumor cell lines, respectively. H Percentage of viable CD70+ tumor cells (Raji, PANC-1 and LIM2099) after a 4 h co-culture with CD70-CAR NK cells or MOCK control cells (n = 5). I Simple linear regression analysis of CD70-CAR NK cell target lysis and density of CD70 expression ( delta MFI) on target cells. Spearman’s correlation was used to analyze the correlation between the CD70 expression and target lysis. Linear mixed models were used to compare means of the lysis of the different tumor targets. ns = p > 0.05; *p < 0.05, **p < 0.01 and ****p < 0.0001 Image collected and cropped by CiteAb from the following open publication (https://jhoonline.biomedcentral.com/articles/10.1186/s13045-024-01525-w), licensed under a CC-BY license. Not internally tested by R&D Systems.Applications for Human CD27/TNFRSF7 Antibody (57703)
CyTOF-ready
Flow Cytometry
Sample: Human whole blood lymphocytes
Western Blot
Sample: Recombinant Human CD27/TNFRSF7 Fc Chimera (Catalog # 382-CD)
Neutralization
Flow Cytometry Panel Builder
Bio-Techne Knows Flow Cytometry
Save time and reduce costly mistakes by quickly finding compatible reagents using the Panel Builder Tool.
Advanced Features
- Spectra Viewer - Custom analysis of spectra from multiple fluorochromes
- Spillover Popups - Visualize the spectra of individual fluorochromes
- Antigen Density Selector - Match fluorochrome brightness with antigen density
Formulation, Preparation, and Storage
Purification
Reconstitution
Reconstitute at 0.5 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Calculators
Background: CD27/TNFRSF7
References
- Camerini, D. et al. (1991) J. Immunol. 147:3165.
- Loenen, W.A. et al. (1992) J. Immunol. 149:3937.
- Lens, S.M.A. et al. (1998) Sem. Immunol. 10:491.
Alternate Names
Gene Symbol
UniProt
Additional CD27/TNFRSF7 Products
Product Documents for Human CD27/TNFRSF7 Antibody (57703)
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Note: Certificate of Analysis not available for kit components.
Product Specific Notices for Human CD27/TNFRSF7 Antibody (57703)
For research use only
Related Research Areas
Citations for Human CD27/TNFRSF7 Antibody (57703)
Customer Reviews for Human CD27/TNFRSF7 Antibody (57703)
There are currently no reviews for this product. Be the first to review Human CD27/TNFRSF7 Antibody (57703) and earn rewards!
Have you used Human CD27/TNFRSF7 Antibody (57703)?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 for a review with an image
$10/€7/£6/$10CAN/¥1110 for a review without an image
Submit a review
Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
- 7-Amino Actinomycin D (7-AAD) Cell Viability Flow Cytometry Protocol
- Cellular Response to Hypoxia Protocols
- Extracellular Membrane Flow Cytometry Protocol
- Flow Cytometry Protocol for Cell Surface Markers
- Flow Cytometry Protocol for Staining Membrane Associated Proteins
- Flow Cytometry Staining Protocols
- Flow Cytometry Troubleshooting Guide
- Intracellular Flow Cytometry Protocol Using Alcohol (Methanol)
- Intracellular Flow Cytometry Protocol Using Detergents
- Intracellular Nuclear Staining Flow Cytometry Protocol Using Detergents
- Intracellular Staining Flow Cytometry Protocol Using Alcohol Permeabilization
- Intracellular Staining Flow Cytometry Protocol Using Detergents to Permeabilize Cells
- Propidium Iodide Cell Viability Flow Cytometry Protocol
- Protocol for Liperfluo
- Protocol for the Characterization of Human Th22 Cells
- Protocol for the Characterization of Human Th9 Cells
- Protocol: Annexin V and PI Staining by Flow Cytometry
- Protocol: Annexin V and PI Staining for Apoptosis by Flow Cytometry
- R&D Systems Quality Control Western Blot Protocol
- Troubleshooting Guide: Fluorokine Flow Cytometry Kits
- Troubleshooting Guide: Western Blot Figures
- Western Blot Conditions
- Western Blot Protocol
- Western Blot Protocol for Cell Lysates
- Western Blot Troubleshooting
- Western Blot Troubleshooting Guide
- View all Protocols, Troubleshooting, Illustrated assays and Webinars